Divi's Laboratories Ltd. (DIVISLAB): Divi's Laboratories Share Price hits fresh 52-week high on 31 August 2026

Published: 31 August 2026 at 3:32 PM IST

Divi's Laboratories Share Price was Rs 9,245, down 0.26% from the previous close of Rs 9,269, even after the stock touched a fresh 52-week high of Rs 9,257.85. The company’s market capitalisation stood at Rs 2,46,062.83 crore. In today’s Divi's Laboratories Share Price Today update, the key event is the yearly high itself, not a company-specific catalyst supplied in the data. The move keeps Divi's Laboratories Stock News and Divi's Laboratories Share News in focus for investors tracking healthcare counters on Univest.

The latest print shows a narrow range around the day’s high, with the opening price at Rs 9,164.60 and the day low at Rs 9,150. The supplied turnover of Rs 11.43 crore adds a factual value marker to the session. For Divi's Laboratories Share Price Today, the combination of a fresh 52-week high, a close slightly below the peak and a large market capitalisation makes the stock relevant for market watchers following Indian Stock Market updates and 52 Week High Stocks.

Divi's Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 9,245
Previous Close	Rs 9,269
Today's Move	Rs -24 (-0.26%)
Open	Rs 9,164.6
High	Rs 9,257.85
Low	Rs 9,150
Turnover	Rs 11.43 crore
Market Capitalisation	Rs 2,46,062.83 crore

Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 9,245 versus the previous close of Rs 9,269, a fall of 0.26%. The stock opened at Rs 9,164.6, reached a high of Rs 9,257.85 and touched a low of Rs 9,150.

Divi's Laboratories Share Price opened at Rs 9,164.60, traded between Rs 9,150 and Rs 9,257.85, and closed at Rs 9,245 against the previous close of Rs 9,269. That leaves a day change of Rs -24 and a day change of -0.26%. The fresh 52-week high of Rs 9,257.85 is slightly above the closing price, so the session confirmed the yearly high even though the stock ended below the previous close.

The supplied turnover of Rs 11.43 crore gives a factual snapshot of the day’s traded value, while the session range shows that the price remained close to the upper end of the day’s band. For Divi's Laboratories Share Price Today, this is the central market fact: a fresh yearly high was printed, but the final close was modestly lower than the prior close. That keeps Divi's Laboratories Stock News relevant for anyone tracking the day’s share price update on Univest.

What exactly happened today is simple and verifiable: Divi's Laboratories touched a new 52-week high, the stock finished at Rs 9,245, and the day ended with a small decline from the previous close. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For the next step, Divi's Laboratories Share Price is best read alongside valuation, profitability and sector context.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,46,062.83 crore
P/E Ratio	84.12x
P/B Ratio	13.93x
ROE	16.19%
ROCE	21.51%
EPS	Rs 110.18
Book Value Per Share	Rs 665.36
Dividend Yield	0.32%

Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 84.12x, P/B 13.93x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.

Divi's Laboratories Ltd. has a market capitalisation of Rs 246062.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.12x, P/B at 13.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.32%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.12x, median ROE of 11.78%, median ROCE of 13.59%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	84.12x
Benchmark Median P/E	31.12x
Benchmark Average P/E	47.89x
Benchmark P/E Range	3.7x to 672.45x
Company P/B Ratio	13.93x
Benchmark Median P/B	2.87x
Company ROE	16.19%
Benchmark Median ROE	11.78%
Company ROCE	21.51%
Benchmark Median ROCE	13.59%
Company Market Capitalisation	Rs 2,46,062.83 crore
Benchmark Median Market Cap	Rs 630.79 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 84.12x, which is above the benchmark median of 31.12x, a difference of +170.31%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.78%, a difference of +37.44%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.59%, a difference of +58.28%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,91,515.22	87.81	21.34	26.76	19.27
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,60,696.31	38.09	5.33	14.85	19.11
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,18,403.7	26.24	4.39	19.69	21.39
Cipla Ltd.	CIPLA	1,14,554.33	33.99	3.26	11.83	16
Laurus Labs Ltd.	LAURUSLABS	1,04,566.62	95.64	18.54	18.31	18.2

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 84.12x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,46,062.83 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories

• Divi's Laboratories Share Price touched a fresh 52-week high of Rs 9,257.85.
• The stock closed at Rs 9,245 after a day change of Rs -24, or -0.26%.
• Market capitalisation stood at Rs 2,46,062.83 crore.
• P/E was 84.12 and P/B was 13.93 in the supplied data.
• ROE was 16.19% and ROCE was 21.51%, both above the sector medians.

About Divi's Laboratories

Divi's Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data in this article focuses on market capitalisation, valuation ratios, profitability metrics and recent financial results rather than a broader business-description profile. On that basis, Divi's Laboratories Share Price is being tracked here through its market data, earnings context and benchmark comparison on Univest. The stock’s latest event is the fresh 52-week high, which places Divi's Laboratories Share Price Today among the notable stock updates in the Indian Stock Market.

Track Divi's Laboratories Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Divi's Laboratories Share Price on Univest for live share price updates, valuation ratios, shareholding pattern, company financials, 52-week levels and market insights. Univest also helps readers review Divi's Laboratories Stock Analysis, Divi's Laboratories Fundamental Analysis and Divi's Laboratories Share Price Live in one place. For investors following Divi's Laboratories News Today, the platform keeps the latest stock context organized without adding speculation.

Frequently Asked Questions

What is Divi's Laboratories Share Price today?

Ans. Divi's Laboratories Share Price was Rs 9,245 in the supplied data. It ended lower by Rs 24, or 0.26%, versus the previous close of Rs 9,269, while still touching a fresh 52-week high.

Did Divi's Laboratories hit a 52-week high today?

Ans. Yes. Divi's Laboratories touched a fresh 52-week high of Rs 9,257.85. The stock closed slightly below that level, but the yearly high was still recorded in the day’s price action.

What was the previous close for Divi's Laboratories Share Price?

Ans. The previous close was Rs 9,269. Divi's Laboratories Share Price then moved to Rs 9,245 at the close, which shows a small decline from the prior session while the 52-week high was set.

What is Divi's Laboratories market capitalisation?

Ans. Divi's Laboratories had a market capitalisation of Rs 2,46,062.83 crore in the supplied data. That places the company well above the sector median market-cap level in the Pharmaceuticals & Drugs benchmark.

How is Divi's Laboratories valued on P/E and P/B?

Ans. Divi's Laboratories was valued at a P/E of 84.12 and a P/B of 13.93. Both figures are above the sector median and average in the supplied healthcare benchmark data. The company trades at a P/E ratio of 84.12x.

What do ROE and ROCE show for Divi's Laboratories?

Ans. Divi's Laboratories posted ROE of 16.19% and ROCE of 21.51%. Both are above the sector medians in the provided benchmark, which gives the share price event useful profitability context. ROE stands at 16.19%.

What are Divi's Laboratories EPS and book value?

Ans. EPS was Rs 110.18 and book value was Rs 665.36. EPS reflects earnings per share, while book value shows accounting net worth per share, both of which help frame Divi's Laboratories Share Price.

What is the dividend yield for Divi's Laboratories?

Ans. Dividend yield was 0.32% in the supplied data. It is a historical or current income measure tied to price, so it should be read alongside valuation, earnings and peer comparisons rather than in isolation.

How does Divi's Laboratories compare with healthcare peers?

Ans. Divi's Laboratories Share Price was compared with Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla and Laurus Labs. Its market capitalisation and profitability ratios place it in a distinct part of the peer set.

Which sector and industry does Divi's Laboratories belong to?

Ans. Divi's Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The stock’s 52-week high is therefore being viewed inside a healthcare and pharma benchmark, not in isolation.